Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1992 1
1993 2
1994 3
1996 1
1998 2
2009 1
2010 3
2011 2
2012 4
2013 3
2014 4
2015 1
2016 4
2017 4
2018 6
2019 5
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

45 results
Results by year
Filters applied: . Clear all
Page 1
Parent-of-origin-specific signatures of de novo mutations.
Goldmann JM, Wong WS, Pinelli M, Farrah T, Bodian D, Stittrich AB, Glusman G, Vissers LE, Hoischen A, Roach JC, Vockley JG, Veltman JA, Solomon BD, Gilissen C, Niederhuber JE. Goldmann JM, et al. Among authors: Farrah T. Nat Genet. 2016 Aug;48(8):935-9. doi: 10.1038/ng.3597. Epub 2016 Jun 20. Nat Genet. 2016. PMID: 27322544
Advances in Therapies and Imaging for Systemic Vasculitis.
Farrah TE, Basu N, Dweck M, Calcagno C, Fayad ZA, Dhaun N. Farrah TE, et al. Arterioscler Thromb Vasc Biol. 2019 Aug;39(8):1520-1541. doi: 10.1161/ATVBAHA.118.310957. Epub 2019 Jun 13. Arterioscler Thromb Vasc Biol. 2019. PMID: 31189432 Review.
A novel role for myeloid endothelin-B receptors in hypertension.
Czopek A, Moorhouse R, Guyonnet L, Farrah T, Lenoir O, Owen E, van Bragt J, Costello HM, Menolascina F, Baudrie V, Webb DJ, Kluth DC, Bailey MA, Tharaux PL, Dhaun N. Czopek A, et al. Among authors: Farrah T. Eur Heart J. 2019 Mar 1;40(9):768-784. doi: 10.1093/eurheartj/ehy881. Eur Heart J. 2019. PMID: 30657897 Free PMC article.
Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease.
Farrah TE, Anand A, Gallacher PJ, Kimmitt R, Carter E, Dear JW, Mills NL, Webb DJ, Dhaun N. Farrah TE, et al. Hypertension. 2019 Aug;74(2):323-330. doi: 10.1161/HYPERTENSIONAHA.119.12919. Epub 2019 Jun 10. Hypertension. 2019. PMID: 31177906 Free PMC article. Clinical Trial.
Cyclophosphamide-Induced Lung Injury.
Pugh D, Farrah TE, Gallacher PJ, Kluth DC, Dhaun N. Pugh D, et al. Among authors: Farrah TE. Kidney Int Rep. 2018 Nov 10;4(3):484-486. doi: 10.1016/j.ekir.2018.11.001. eCollection 2019 Mar. Kidney Int Rep. 2018. PMID: 30899875 Free PMC article. No abstract available.
ANCA associated vasculitis.
Hunter RW, Welsh N, Farrah TE, Gallacher PJ, Dhaun N. Hunter RW, et al. Among authors: Farrah TE. BMJ. 2020 Apr 14;369:m1070. doi: 10.1136/bmj.m1070. BMJ. 2020. PMID: 32291255 Free PMC article. No abstract available.
Long-term outcomes in elderly patients with ANCA-associated vasculitis.
McGovern D, Williams SP, Parsons K, Farrah TE, Gallacher PJ, Miller-Hodges E, Kluth DC, Hunter RW, Dhaun N. McGovern D, et al. Among authors: Farrah TE. Rheumatology (Oxford). 2020 May 1;59(5):1076-1083. doi: 10.1093/rheumatology/kez388. Rheumatology (Oxford). 2020. PMID: 31794032
Pharmacological Effects of RAAS Blockade in Ischemic Nephropathy.
Rivoli L, Di Mario F, Coppolino G, Gigante A, Barbano B, Farrah TE, Rosato E, Fuiano G, Cianci R. Rivoli L, et al. Among authors: Farrah TE. Curr Drug Metab. 2016;17(6):550-8. doi: 10.2174/1389200217666160219114443. Curr Drug Metab. 2016. PMID: 26892730 Review.
45 results
Jump to page
Feedback